SP110 and cancer: Only TAF1L was not detected in any of the cancer types examined and BRDT, CECR2, SP140, HDAC9, SIRT4, SP110, and TRIM66 had restricted expression in 5, 17, 23, 25, 30, 32, and 32 cancer types, respectively (Fig. 1b).